Top Wall Street Forecasters Revamp Zoetis Expectations Ahead Of Q4 Earnings

Zoetis (NYSE:ZTS) set to report Q4 results on Thursday, February 12

Published on Feb. 12, 2026

Got story updates? Submit your updates here. ›

Zoetis Inc. (NYSE:ZTS), the Parsippany, New Jersey-based animal health company, is scheduled to release its fourth quarter earnings before the market opens on Thursday, February 12. Analysts expect the company to report quarterly earnings of $1.4 per share, compared to $1.4 per share in the year-ago period, and quarterly revenue of $2.36 billion, up from $2.32 billion last year.

Why it matters

Zoetis is a major player in the animal health industry, providing medicines and vaccines for pets as well as livestock. The company's quarterly earnings report will provide insight into the overall health of the animal health market and Zoetis' performance relative to expectations.

The details

On December 16, Zoetis announced the pricing of a $1.75 billion convertible senior notes offering. Shares of Zoetis rose 0.4% to close at $128.67 on Wednesday, February 11.

  • Zoetis will release its Q4 2025 earnings before the market opens on Thursday, February 12, 2026.

The players

Zoetis Inc.

A global animal health company that develops and commercializes medicines and vaccines for pets, livestock, and other animals.

Got photos? Submit your photos here. ›

The takeaway

Investors will be closely watching Zoetis' Q4 earnings report for signs of continued growth in the animal health market and the company's ability to execute on its strategic initiatives.